JPMorgan Chase & Co’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$882M Buy
10,638,105
+268,399
+3% +$22.3M 0.06% 270
2025
Q1
$841M Buy
10,369,706
+2,360,858
+29% +$191M 0.06% 260
2024
Q4
$721M Sell
8,008,848
-4,266,737
-35% -$384M 0.05% 281
2024
Q3
$1.21B Sell
12,275,585
-49,705
-0.4% -$4.91M 0.09% 200
2024
Q2
$1.14B Buy
12,325,290
+4,479,443
+57% +$415M 0.09% 196
2024
Q1
$744M Buy
7,845,847
+3,747,406
+91% +$356M 0.06% 269
2023
Q4
$366M Sell
4,098,441
-780,484
-16% -$69.7M 0.04% 408
2023
Q3
$356M Sell
4,878,925
-205,327
-4% -$15M 0.04% 371
2023
Q2
$423M Sell
5,084,252
-2,450,219
-33% -$204M 0.05% 330
2023
Q1
$574M Buy
7,534,471
+4,835,071
+179% +$368M 0.07% 266
2022
Q4
$224M Buy
2,699,400
+162,805
+6% +$13.5M 0.03% 453
2022
Q3
$201M Buy
2,536,595
+1,822,559
+255% +$145M 0.03% 461
2022
Q2
$53M Buy
714,036
+256,652
+56% +$19.1M 0.01% 928
2022
Q1
$41.1M Buy
457,384
+239,398
+110% +$21.5M 0.01% 1141
2021
Q4
$24.4M Sell
217,986
-2,422,464
-92% -$271M ﹤0.01% 1436
2021
Q3
$332M Sell
2,640,450
-1,912,098
-42% -$240M 0.04% 399
2021
Q2
$616M Sell
4,552,548
-2,240,031
-33% -$303M 0.07% 259
2021
Q1
$921M Buy
6,792,579
+5,825,292
+602% +$790M 0.12% 172
2020
Q4
$136M Sell
967,287
-9,572,202
-91% -$1.35B 0.02% 623
2020
Q3
$1.18B Sell
10,539,489
-35,855
-0.3% -$4M 0.2% 103
2020
Q2
$1.18B Buy
10,575,344
+721,657
+7% +$80.8M 0.23% 96
2020
Q1
$763M Buy
9,853,687
+9,752,095
+9,599% +$755M 0.18% 117
2019
Q4
$9.66M Sell
101,592
-6,519,760
-98% -$620M ﹤0.01% 1789
2019
Q3
$505M Buy
6,621,352
+2,648,125
+67% +$202M 0.1% 205
2019
Q2
$341M Sell
3,973,227
-788,686
-17% -$67.8M 0.07% 288
2019
Q1
$431M Buy
4,761,913
+1,720,255
+57% +$156M 0.09% 237
2018
Q4
$218M Sell
3,041,658
-224,057
-7% -$16.1M 0.05% 348
2018
Q3
$313M Buy
3,265,715
+1,622,372
+99% +$156M 0.06% 310
2018
Q2
$156M Buy
1,643,343
+180,743
+12% +$17.2M 0.03% 470
2018
Q1
$128M Buy
1,462,600
+573,431
+64% +$50.3M 0.03% 507
2017
Q4
$75.5M Sell
889,169
-1,139,375
-56% -$96.7M 0.02% 711
2017
Q3
$174M Sell
2,028,544
-1,004,305
-33% -$86.2M 0.04% 428
2017
Q2
$234M Sell
3,032,849
-346,845
-10% -$26.8M 0.05% 344
2017
Q1
$234M Buy
3,379,694
+2,229,892
+194% +$155M 0.05% 332
2016
Q4
$68.1M Buy
1,149,802
+436,816
+61% +$25.9M 0.02% 678
2016
Q3
$47.3M Sell
712,986
-1,633,237
-70% -$108M 0.01% 796
2016
Q2
$127M Sell
2,346,223
-762,989
-25% -$41.3M 0.03% 457
2016
Q1
$161M Sell
3,109,212
-812,209
-21% -$42M 0.04% 399
2015
Q4
$275M Buy
3,921,421
+2,498
+0.1% +$175K 0.07% 289
2015
Q3
$244M Sell
3,918,923
-354,592
-8% -$22.1M 0.07% 295
2015
Q2
$359M Buy
4,273,515
+535,992
+14% +$45.1M 0.08% 251
2015
Q1
$281M Sell
3,737,523
-2,721,258
-42% -$205M 0.06% 323
2014
Q4
$401M Sell
6,458,781
-292,095
-4% -$18.2M 0.09% 246
2014
Q3
$351M Buy
6,750,876
+300,876
+5% +$15.6M 0.08% 262
2014
Q2
$331M Sell
6,450,000
-306,282
-5% -$15.7M 0.08% 272
2014
Q1
$321M Buy
6,756,282
+2,316
+0% +$110K 0.09% 247
2013
Q4
$293M Sell
6,753,966
-600,375
-8% -$26.1M 0.08% 257
2013
Q3
$317M Buy
7,354,341
+754,224
+11% +$32.5M 0.09% 239
2013
Q2
$229M Buy
+6,600,117
New +$229M 0.07% 278